Annual Drug Patent Expirations for PROLENSA
Prolensa is a drug marketed by Bausch And Lomb and is included in one NDA. It is available from two suppliers. There are nine patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for PROLENSA.
This drug has twenty-three patent family members in thirteen countries.
The generic ingredient in PROLENSA is bromfenac sodium. Two suppliers are listed for this compound. Additional details are available on the bromfenac sodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com